137 related articles for article (PubMed ID: 36254860)
21. Olecranon bursitis secondary to Mycobacterium kansasii infection in a patient receiving infliximab for Behcet's disease.
Malkin J; Shrimpton A; Wiselka M; Barer MR; Duddridge M; Perera N
J Med Microbiol; 2009 Mar; 58(Pt 3):371-373. PubMed ID: 19208889
[TBL] [Abstract][Full Text] [Related]
22. Tenosynovitis of the right hand. Mycobacterium kansasii.
Formanoy E; Lam HY; Arends JE
Neth J Med; 2013 Dec; 71(10):526, 530. PubMed ID: 24394739
[No Abstract] [Full Text] [Related]
23. Rifabutin in combination with clofazimine, isoniazid and ethambutol in the treatment of AIDS patients with infections due to opportunist mycobacteria. Groupe d'Etude et de Traitement des Infections à Mycobacteries Résistantes.
Dautzenberg B; Truffot C; Mignon A; Rozenbaum W; Katlama C; Perronne C; Parrot R; Grosset J
Tubercle; 1991 Sep; 72(3):168-75. PubMed ID: 1663282
[TBL] [Abstract][Full Text] [Related]
24. An unusual lung mass post stem cell transplantation.
Lyons J; Vandenberghe E; Fahy R; McDonnell C; Keane J; McLaughlin AM
Transpl Infect Dis; 2014 Aug; 16(4):672-5. PubMed ID: 24995624
[TBL] [Abstract][Full Text] [Related]
25. Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease.
Santin M; Dorca J; Alcaide F; Gonzalez L; Casas S; Lopez M; Guerra MR
Eur Respir J; 2009 Jan; 33(1):148-52. PubMed ID: 19118226
[TBL] [Abstract][Full Text] [Related]
26. Tuberculosis due to Mycobacterium kansasii.
Elder JL; Edwards FG; Abrahams EW
Aust N Z J Med; 1977 Feb; 7(1):8-13. PubMed ID: 266899
[TBL] [Abstract][Full Text] [Related]
27. Rifabutin versus placebo in combination with three drugs in the treatment of nontuberculous mycobacterial infection in patients with AIDS.
Dautzenberg B; Olliaro P; Ruf B; Esposito R; Opravil M; Hoy JF; Rozenbaum W; Carosi GP; Micoud M; L'Age M; Pirotta N; Sassella D
Clin Infect Dis; 1996 Apr; 22(4):705-8. PubMed ID: 8729209
[TBL] [Abstract][Full Text] [Related]
28. Disseminated Mycobacterium kansasii infection with cutaneous lesions in an immunocompetent patient.
Zhang M; Feng M; He JQ
Int J Infect Dis; 2017 Sep; 62():59-63. PubMed ID: 28712930
[TBL] [Abstract][Full Text] [Related]
29. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
Research Committee of the British Thoracic Society
Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
[TBL] [Abstract][Full Text] [Related]
30. Mycobacterium kansasii: antibiotic susceptibility and PCR-restriction analysis of clinical isolates.
da Silva Telles MA; Chimara E; Ferrazoli L; Riley LW
J Med Microbiol; 2005 Oct; 54(Pt 10):975-979. PubMed ID: 16157553
[TBL] [Abstract][Full Text] [Related]
31. Treatment of septic arthritis due to Mycobacterium kansasii.
Carroll SR; Newson SW; Jenner JR
Br Med J (Clin Res Ed); 1984 Sep; 289(6445):591-2. PubMed ID: 6432204
[No Abstract] [Full Text] [Related]
32. Mycobacterium kansasii pericarditis in a kidney transplant recipient: a case report and comprehensive review of the literature.
Cho JH; Yu CH; Jin MK; Kwon O; Hong KD; Choi JY; Yoon SH; Park SH; Kim CD; Kim YL
Transpl Infect Dis; 2012 Oct; 14(5):E50-5. PubMed ID: 22823928
[TBL] [Abstract][Full Text] [Related]
33. A case of wrist tenosynovitis caused by Mycobacterium kansasii in a renal transplant recipient.
Chan A; Findlay A; Abeygunasekara S
Transpl Infect Dis; 2012 Oct; 14(5):E44-9. PubMed ID: 22822725
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary
Saranathan R; Padmapriyadarsini C; Sivaramakrishnan GN; Perumal BK; Kannayan S; Joseph B; Gopalan N; Hanna LE
Indian J Med Microbiol; 2019; 37(1):127-131. PubMed ID: 31424025
[TBL] [Abstract][Full Text] [Related]
35. Cavitary lung infection caused by Mycobacterium flavescens.
Casimir MT; Fainstein V; Papadopolous N
South Med J; 1982 Feb; 75(2):253-4. PubMed ID: 7058379
[No Abstract] [Full Text] [Related]
36. Disseminated Mycobacterium kansasii infection associated with skin lesions: a case report and comprehensive review of the literature.
Han SH; Kim KM; Chin BS; Choi SH; Lee HS; Kim MS; Jeong SJ; Choi HK; Kim CO; Choi JY; Song YG; Kim JM
J Korean Med Sci; 2010 Feb; 25(2):304-8. PubMed ID: 20119588
[TBL] [Abstract][Full Text] [Related]
37. Mycobacterium kansasii osteomyelitis in a patient with AIDS on highly active antiretroviral therapy.
Yano T; Okuda S; Kato K; Kato K; Kishimoto T
Intern Med; 2004 Nov; 43(11):1084-6. PubMed ID: 15609709
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment.
Jenkins PA; Campbell IA;
Respir Med; 2003 Apr; 97(4):439-44. PubMed ID: 12693807
[TBL] [Abstract][Full Text] [Related]
39. [Mycobacterial kansasii pulmonary infection: atypical presentation].
Carballal Regidor JM; Montero Martínez C; Verea Hernando H
Arch Bronconeumol; 1999 Sep; 35(8):410-1. PubMed ID: 10548989
[No Abstract] [Full Text] [Related]
40. Short-course chemotherapy for pulmonary disease caused by Mycobacterium kansasii.
Ahn CH; Lowell JR; Ahn SS; Ahn SI; Hurst GA
Am Rev Respir Dis; 1983 Dec; 128(6):1048-50. PubMed ID: 6650978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
